Scarica l'app Stockscreener
30.50
0.13%
-0.04
Dopo l'orario di chiusura:
30.50
Precedente Chiudi:
$30.54
Aprire:
$30.29
Volume 24 ore:
754.16K
Relative Volume:
0.62
Capitalizzazione di mercato:
$2.34B
Reddito:
$13.17M
Utile/perdita netta:
$-199.06M
Rapporto P/E:
-11.13
EPS:
-2.74
Flusso di cassa netto:
$-156.53M
1 W Prestazione:
+0.66%
1M Prestazione:
-4.95%
6M Prestazione:
-23.71%
1 anno Prestazione:
-30.25%
Intervallo 1D:
$30.00
$30.74
Intervallo di 1 settimana:
$30.00
$31.87
Portata 52W:
$26.74
$46.00
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
Nome
Xenon Pharmaceuticals Inc
Settore
Industria
Telefono
(604) 484-3300
Indirizzo
200 - 3650 GILMORE WAY, BURNABY
Confronta XENE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
30.50 | 2.34B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-10-01 | Iniziato | H.C. Wainwright | Buy |
| 2024-01-04 | Iniziato | Citigroup | Buy |
| 2023-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-04-25 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-14 | Iniziato | Goldman | Buy |
| 2022-12-12 | Iniziato | Cowen | Outperform |
| 2022-11-28 | Iniziato | Wells Fargo | Overweight |
| 2022-10-19 | Iniziato | Raymond James | Outperform |
| 2022-08-29 | Iniziato | BofA Securities | Buy |
| 2022-07-21 | Iniziato | JP Morgan | Overweight |
| 2021-10-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-10-02 | Iniziato | SVB Leerink | Outperform |
| 2020-07-21 | Iniziato | Needham | Buy |
| 2020-06-01 | Ripresa | Jefferies | Buy |
| 2020-03-25 | Iniziato | Wedbush | Outperform |
| 2020-01-08 | Iniziato | William Blair | Outperform |
| 2019-09-20 | Iniziato | Guggenheim | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2017-03-13 | Iniziato | Jefferies | Buy |
| 2016-10-21 | Iniziato | Stifel | Buy |
| 2016-09-26 | Iniziato | Guggenheim | Buy |
| 2016-04-14 | Reiterato | Jefferies | Buy |
| 2015-10-30 | Ripresa | Jefferies | Buy |
| 2014-12-02 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie
What drives Xenon Pharmaceuticals Inc. stock priceGet professional guidance for market timing - jammulinksnews.com
What are the latest earnings results for Xenon Pharmaceuticals Inc.Discover the fastest growing stocks today - jammulinksnews.com
When is Xenon Pharmaceuticals Inc. stock expected to show significant growthUnlock exclusive stock market insights - jammulinksnews.com
How does Xenon Pharmaceuticals Inc. compare to its industry peersFree Daily Trading Room Entry - jammulinksnews.com
What is Xenon Pharmaceuticals Inc. company’s growth strategyRapid growth opportunities - jammulinksnews.com
Is Xenon Pharmaceuticals Inc. a good long term investmentBuild wealth with proven stock investing tactics - jammulinksnews.com
What’s the recovery path for long term holders of Xenon Pharmaceuticals Inc.Free Fundamental + Technical Hybrid Stock Tips - Newser
Xenon Pharmaceuticals Inc. Stock Analysis and ForecastCapitalize on market momentum for profits - jammulinksnews.com
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Sold by Federated Hermes Inc. - Defense World
Using data tools to time your Xenon Pharmaceuticals Inc. exitFree Oversold Recovery Opportunity Stocks - Newser
Is Xenon Pharmaceuticals Inc. still worth holding after the dipAI Trend Detection for Entry Timing - Newser
Is Xenon Pharmaceuticals Inc. stock poised for growthSmart Money Strategy for Growth Stocks - Newser
Is a relief rally coming for Xenon Pharmaceuticals Inc. holdersFree Accurate Technical Trend Reversal Picks - Newser
Is it the right time to buy Xenon Pharmaceuticals Inc. stockGain access to exclusive stock analysis - jammulinksnews.com
What is the dividend policy of Xenon Pharmaceuticals Inc. stockUnlock expert market analysis instantly - jammulinksnews.com
Is Xenon Pharmaceuticals Inc. stock overvalued or undervaluedFree Stock Market Knowledge Sharing - jammulinksnews.com
How volatile is Xenon Pharmaceuticals Inc. stock compared to the marketBreakneck growth rates - jammulinksnews.com
Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees - The Globe and Mail
Xenon Pharmaceuticals Inc. stock trend forecastSafe Investment Ideas with Growth Upside - Newser
Assetmark Inc. Has $669,000 Stock Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Using economic indicators to assess Xenon Pharmaceuticals Inc. potentialHigh Reward Picks with Tight Risk Control - Newser
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Short Interest Update - Defense World
Visual analytics tools that track Xenon Pharmaceuticals Inc. performanceTechnical Screener for High Growth Stocks - Newser
Xenon Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Risk Managed Intraday Trade Alerts - Newser
Has Xenon Pharmaceuticals Inc. found a price floorRisk Managed Watchlist with Breakout Picks - Newser
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Xenon Pharmaceuticals Expands Team: Grants $739K in Stock Options to 6 New Hires - Stock Titan
Will Xenon Pharmaceuticals Inc. continue its uptrendDividend Strategy Summary With 10-Year Outlook - newser.com
Envestnet Asset Management Inc. Sells 4,447 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Can you recover from losses in Xenon Pharmaceuticals Inc.Free Entry Zone Strategy for Consistent Profit - Newser
Why Xenon Pharmaceuticals Inc. stock attracts strong analyst attentionTrend Confirmation Scanner with Entry Focus - Newser
How Xenon Pharmaceuticals Inc. stock performs during market volatilityFree Breakout Momentum Picks With Protection - Newser
Identifying reversal signals in Xenon Pharmaceuticals Inc.Chart Risk Profile for Capital Preservation - Newser
Sector ETF performance correlation with Xenon Pharmaceuticals Inc.Free Trade Insight With Community Collaboration - Newser
Skandinaviska Enskilda Banken AB publ Acquires 7,081 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Sold by Fiera Capital Corp - Defense World
Should I buy Xenon Pharmaceuticals Inc. stock before earningsFree Breakout Entry Signal Confirmation Tool - Newser
What technical models suggest about Xenon Pharmaceuticals Inc.’s comebackStock Portfolio Risk and Return Analysis - Newser
Xenon Pharmaceuticals Inc. Recovery Gathers Momentum on Chart SignalsTrend Analysis for Safer Trades Gains Popularity - metal.it
Published on: 2025-07-29 06:12:13 - metal.it
Is Xenon Pharmaceuticals Inc. a growth stock or a value stockEarnings Report Entry Points For Fast Growth - jammulinksnews.com
What institutional investors are buying Xenon Pharmaceuticals Inc. stockExpert Picks Outlook To Watch Now - jammulinksnews.com
Xenon Pharmaceuticals Inc Azioni (XENE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):